C4 Therapeutics Inc.

C4 Therapeutics Inc.

World Rank (Jan-05-2024)
15,530
Market Cap (Jan-05-2024)
0.312 Billion USD
World Rank (Jul-30-2023)
18,493
Market Cap (Jul-30-2023)
0.184 Billion USD
World Rank (Jan-07-2022)
8,020
Market Cap (Jan-07-2022)
1.318 Billion USD
World Rank (Jan-01-2021)
6,573
Market Cap (Jan-01-2021)
1.426 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
CCCC
Market Cap (Mar-08-2026)
0.30
Employee Count
121
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
45 Million USD
Annual Net Income in USD
-83 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
506 Million USD
Total Liabilities in USD
117 Million USD
Total Equity in USD
389 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
C4 THERAPEUTICS, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
C4 Therapeutics is a Biopharmaceutical company committed to transforming the treatment of cancer, neurological and other important diseases with novel early stage therapies that eliminate disease causing proteins. The company annual revenue is 21.38 million USD and 97 employees as on 2019. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share